Basic Information
RNALocate ID: | RLID-D:11000452 |
RNA Symbol: | hsa-miR-429 |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-429 |
RNA ID: | miRBase:MIMAT0001536 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11002768 | Exosome | Serum | 18589210 |
RLID:11002769 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11002770 | Exosome | Brain tissue | 23382797 |
RLID:11002771 | Exosome | Plasma | 23663360 |
RLID-D:11000139 | Exosome | Breast milk|Colon tissue|Seminal fluid|Tongue tissue |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-mir-429 | Oral squamous cell carcinoma | MNDR-E-MI-49322 |
MNDR | hsa-miR-429 | Oral squamous cell carcinoma | MNDR-E-MI-49323 |
MNDR | hsa-miR-429 | Large cell neuroendocrine cancer | MNDR-E-MI-49324 |
MNDR | hsa-miR-429 | High-grade serous ovarian carcinoma | MNDR-E-MI-49325 |
MNDR | hsa-miR-429 | Uterine corpus endometrial carcinoma | MNDR-E-MI-49326 |
MNDR | hsa-mir-429 | Immunoglobulin a deficiency | MNDR-E-MI-49327 |
MNDR | hsa-mir-429 | Non-hodgkin lymphoma somatic | MNDR-E-MI-49328 |
MNDR | hsa-miR-429 | Estrogen-receptor positive breast cancer | MNDR-E-MI-49329 |
MNDR | hsa-miR-429 | Estrogen-receptor negative breast cancer | MNDR-E-MI-49330 |
MNDR | hsa-miR-429 | Progesterone-receptor positive breast cancer | MNDR-E-MI-49331 |
MNDR | hsa-miR-429 | Progesterone-receptor negative breast cancer | MNDR-E-MI-49332 |
MNDR | hsa-miR-429 | Her2-receptor positive breast cancer | MNDR-E-MI-49333 |
MNDR | hsa-miR-429 | Breast cancer luminal | MNDR-E-MI-49334 |
MNDR | hsa-mir-429 | Colorectal carcinoma | MNDR-E-MI-49335 |
MNDR | hsa-mir-429 | Fatty liver non-alcoholic | MNDR-E-MI-49336 |
MNDR | hsa-mir-429 | Prostate cancer | MNDR-E-MI-49337 |
MNDR | hsa-mir-429 | Leukemia/lymphoma chronic b-cell | MNDR-E-MI-49338 |
MNDR | hsa-miR-429 | Hirschsprung disease | MNDR-E-MI-49339 |
MNDR | hsa-mir-429 | Gastric cancer | MNDR-E-MI-49340 |
MNDR | hsa-miR-429 | Gastric cancer | MNDR-E-MI-49341 |
MNDR | hsa-miR-429 | Alzheimer disease | MNDR-E-MI-49342 |
MNDR | hsa-mir-429 | Bladder cancer | MNDR-E-MI-49343 |
MNDR | hsa-miR-429 | Bladder cancer | MNDR-E-MI-49344 |
MNDR | hsa-mir-429 | Carcinoma esophageal | MNDR-E-MI-49345 |
MNDR | hsa-miR-429 | Gilles de la tourette syndrome | MNDR-E-MI-49346 |
MNDR | hsa-mir-429 | Nephrosclerosis | MNDR-E-MI-49347 |
MNDR | hsa-mir-429 | Cardiomyopathy dilated | MNDR-E-MI-49348 |
MNDR | hsa-miR-429 | Lung cancer | MNDR-E-MI-49349 |
MNDR | hsa-mir-429 | Lung cancer | MNDR-E-MI-49350 |
MNDR | hsa-mir-429 | Endometrial cancer | MNDR-E-MI-49351 |
MNDR | hsa-miR-429 | Endometrial cancer | MNDR-E-MI-49352 |
MNDR | hsa-mir-429 | Azoospermia | MNDR-E-MI-49353 |
MNDR | hsa-miR-429 | Parkinson disease | MNDR-E-MI-49354 |
MNDR | hsa-miR-429 | Machado-joseph disease | MNDR-E-MI-49355 |
MNDR | hsa-miR-429 | Basal-like breast cancer | MNDR-E-MI-49356 |
MNDR | hsa-mir-429 | Breast cancer | MNDR-E-MI-49357 |
MNDR | hsa-mir-429 | Cancer | MNDR-E-MI-49358 |
MNDR | hsa-miR-429 | Cancer | MNDR-E-MI-49359 |
MNDR | hsa-miR-429 | Thyroid cancer | MNDR-E-MI-49360 |
MNDR | hsa-miR-429 | Pituitary neoplasms | MNDR-E-MI-49361 |
MNDR | hsa-mir-429 | Pancreatic cancer | MNDR-E-MI-49362 |
MNDR | hsa-miR-429 | Pancreatic cancer | MNDR-E-MI-49363 |
MNDR | hsa-mir-429 | Malignant melanoma | MNDR-E-MI-49364 |
MNDR | hsa-miR-429 | Melanoma | MNDR-E-MI-49365 |
MNDR | hsa-miR-429 | Rectum adenocarcinoma | MNDR-E-MI-49366 |
MNDR | hsa-mir-429 | Nephroblastoma | MNDR-E-MI-49367 |
MNDR | hsa-miR-429 | Nephroblastoma | MNDR-E-MI-49368 |
MNDR | hsa-miR-429 | Colon cancer | MNDR-E-MI-49369 |
MNDR | hsa-mir-429 | Colon cancer | MNDR-E-MI-49370 |
MNDR | hsa-miR-429 | Colon adenocarcinoma | MNDR-E-MI-49371 |
MNDR | hsa-mir-429 | Ovarian cancer | MNDR-E-MI-49372 |
MNDR | hsa-miR-429 | Ovarian cancer | MNDR-E-MI-49373 |
MNDR | hsa-mir-429 | Adenocarcinoma endometrial | MNDR-E-MI-49374 |
MNDR | hsa-miR-429 | Endometrial endometrioid carcinoma | MNDR-E-MI-49375 |
MNDR | hsa-mir-429 | Endometriosis | MNDR-E-MI-49376 |
MNDR | hsa-mir-429 | Glomerulonephritis | MNDR-E-MI-49377 |
MNDR | hsa-mir-429 | Iga glomerulonephritis | MNDR-E-MI-49378 |
MNDR | hsa-mir-429 | Adenocarcinoma | MNDR-E-MI-49379 |
MNDR | hsa-miR-429 | Carcinoma ductal breast | MNDR-E-MI-49380 |
MNDR | hsa-mir-429 | Glioblastoma | MNDR-E-MI-49381 |
MNDR | hsa-mir-429 | Astrocytoma | MNDR-E-MI-49382 |
MNDR | hsa-mir-429 | Glioma | MNDR-E-MI-49383 |
MNDR | hsa-miR-429 | Malignant glioma | MNDR-E-MI-49384 |
MNDR | hsa-miR-429 | Temporal lobe epilepsy | MNDR-E-MI-49385 |
MNDR | hsa-mir-429 | Osteosarcoma | MNDR-E-MI-49386 |
MNDR | hsa-mir-429 | Mesenchymal cancer | MNDR-E-MI-49387 |
MNDR | hsa-miR-429 | Pediatric osteosarcoma | MNDR-E-MI-49388 |
MNDR | hsa-miR-429 | Liposarcoma | MNDR-E-MI-49389 |
MNDR | hsa-miR-429 | Breast carcinoma | MNDR-E-MI-49390 |
MNDR | hsa-mir-429 | Adenocarcinoma pancreatic ductal | MNDR-E-MI-49391 |
MNDR | hsa-miR-429 | Liver cancer | MNDR-E-MI-49392 |
MNDR | hsa-mir-429 | Liver neoplasms | MNDR-E-MI-49393 |
MNDR | hsa-miR-429 | Cervical adenocarcinoma | MNDR-E-MI-49394 |
MNDR | hsa-miR-429 | Gastric adenocarcinoma | MNDR-E-MI-49395 |
MNDR | hsa-miR-429 | Cervical squamous cell carcinoma | MNDR-E-MI-49396 |
MNDR | hsa-miR-429 | Pituitary adenoma | MNDR-E-MI-49397 |
MNDR | hsa-miR-429 | Lung squamous cell carcinoma | MNDR-E-MI-49398 |
MNDR | hsa-mir-429 | Carcinoma lung non-small-cell | MNDR-E-MI-49399 |
MNDR | hsa-miR-429 | Carcinoma lung non-small-cell | MNDR-E-MI-49400 |
MNDR | hsa-mir-429 | Lung adenocarcinoma | MNDR-E-MI-49401 |
MNDR | hsa-miR-429 | Lung adenocarcinoma | MNDR-E-MI-49402 |
MNDR | hsa-miR-429 | Thyroid carcinoma | MNDR-E-MI-49403 |
MNDR | hsa-miR-429 | Papillary thyroid cancer | MNDR-E-MI-49404 |
MNDR | hsa-miR-429 | Ovarian carcinoma | MNDR-E-MI-49405 |
MNDR | hsa-miR-429 | Bladder urothelial carcinoma | MNDR-E-MI-49406 |
MNDR | hsa-mir-429 | Cervical cancer | MNDR-E-MI-49407 |
MNDR | hsa-mir-429 | Carcinoma renal cell | MNDR-E-MI-49408 |
MNDR | hsa-miR-429 | Carcinoma renal cell | MNDR-E-MI-49409 |
MNDR | hsa-miR-429 | Kidney renal papillary cell carcinoma | MNDR-E-MI-49410 |
MNDR | hsa-miR-429 | Clear cell renal cell carcinoma | MNDR-E-MI-49411 |
MNDR | hsa-miR-429 | Biliary tract cancer | MNDR-E-MI-49412 |
MNDR | hsa-miR-429 | Intrahepatic cholangiocarcinoma | MNDR-E-MI-49413 |
MNDR | hsa-miR-429 | Cholangiocarcinoma | MNDR-E-MI-49414 |
MNDR | hsa-miR-429 | Esophageal cancer | MNDR-E-MI-49415 |
MNDR | hsa-mir-429 | Carcinoma ehrlich tumor | MNDR-E-MI-49416 |
MNDR | hsa-miR-429 | Lung small cell carcinoma | MNDR-E-MI-49417 |
MNDR | hsa-miR-429 | Gastric carcinoma | MNDR-E-MI-49418 |
MNDR | hsa-miR-429 | Testicular germ cell cancer | MNDR-E-MI-49419 |
MNDR | hsa-mir-429 | Heart failure | MNDR-E-MI-49420 |
MNDR | hsa-miR-429 | Breast invasive carcinoma | MNDR-E-MI-49421 |
MNDR | hsa-mir-429 | Carcinoma hepatocellular | MNDR-E-MI-49422 |
MNDR | hsa-miR-429 | Hepatocellular carcinoma | MNDR-E-MI-49423 |
MNDR | hsa-miR-429 | Retinoblastoma | MNDR-E-MI-49424 |
MNDR | hsa-mir-429 | Leukemia chronic myeloid | MNDR-E-MI-49425 |
MNDR | hsa-miR-429 | Ulcerative colitis | MNDR-E-MI-49426 |
MNDR | hsa-mir-429 | Mouth neoplasms | MNDR-E-MI-49427 |
MNDR | hsa-miR-429 | Crohn disease | MNDR-E-MI-49428 |
MNDR | hsa-miR-429 | Tonsil cancer | MNDR-E-MI-49429 |
MNDR | hsa-mir-429 | Systemic lupus erythematosus | MNDR-E-MI-49430 |
MNDR | hsa-mir-429 | Leukemia acute myeloid | MNDR-E-MI-49431 |
MNDR | hsa-mir-429 | Barrett's esophagus | MNDR-E-MI-49432 |
MNDR | hsa-mir-429 | Colorectal cancer | MNDR-E-MI-49433 |
MNDR | hsa-miR-429 | Colorectal cancer | MNDR-E-MI-49434 |
MNDR | hsa-miR-429 | Nasopharynx carcinoma | MNDR-E-MI-49435 |
MNDR | hsa-miR-429 | Ovarian epithelial cancer | MNDR-E-MI-49436 |
MNDR | hsa-mir-429 | Helplessness learned | MNDR-E-MI-49437 |
MNDR | hsa-miR-429 | Nasopharyngeal cancer | MNDR-E-MI-49438 |
MNDR | hsa-mir-429 | Myocardial ischemia | MNDR-E-MI-49439 |
MNDR | hsa-miR-429 | Breast cancer her3+ negative | MNDR-E-MI-49440 |
MNDR | hsa-miR-429 | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-49441 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BAP1 | Homo sapiens | RR00211603 |
TOP